Connecticut Capital Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
1,039
+21
+2% +$21.5K 1% 23
2026
Q1
$936K Sell
1,018
-16
-2% -$16.2K 0.88% 27
2025
Q4
$1.11M Buy
+1,034
New +$989K 1.06% 21

Other funds holding LLY

Connecticut Capital Management Group's LLY Position: Q2 2026 in Review

Connecticut Capital Management Group increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $21.5K and bringing the position to 1,039 shares worth $1.25M. The position accounts for 1% of the portfolio, ranked #23.

Connecticut Capital Management Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Connecticut Capital Management Group held 1,039 shares of Eli Lilly worth $1.25M as of Q2 2026.
  • Connecticut Capital Management Group bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 1% of Connecticut Capital Management Group's portfolio in Q2 2026, its #23 holding.
  • Connecticut Capital Management Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Connecticut Capital Management Group's 13F filing for Q2 2026, filed 20 Jul 2026.